RxNorm Release Notes
March Release - 03/07/2022
For additional information about RxNorm releases, including scripts for loading the RxNorm data into Oracle and MySQL databases, read the RxNorm Technical Documentation.
Sources
The following sources with version names in bold have been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| Vaccines Administered | CVX | CVX_2022_02_14 |
| DrugBank | DRUGBANK | DRUGBANK5.0_2022_02_03 |
| Gold Standard Drug Database | GS | GS_2022_02_09 |
| Multum MediSource Lexicon | MMSL | MMSL_2022_02_01 |
| Micromedex RED BOOK | MMX | MMX_2022_02_07 |
| FDA Structured Product Labels | MTHSPL | MTHSPL_2022_02_25 |
| FDB MedKnowledge (formerly NDDF Plus) | NDDF | NDDF_2022_02_09 |
| RxNorm normalized names and codes | RXNORM | RXNORM_20AA_220307F |
| US Edition of SNOMED CT (drug information) | SNOMEDCT_US | SNOMEDCT_US_2022_01_31 |
| USP Compendial Nomenclature | USP | USP_2022_2_15 |
| Veterans Health Administration National Drug File | VANDF | VANDF_2021_01_31 |
The following sources have not been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| Anatomical Therapeutic Chemical Classification System | ATC | ATC_2021 |
| Medical Subject Headings (MeSH) | MSH | MSH2022_2021_07_20 |
| CMS Formulary Reference File | MTHCMSFRF | MTHCMSFRF_2020 |
*Reminder: As of October 2017, Medi-Span data will not be included in the RxNorm or UMLS releases. If you have questions about Medi-Span, please contact: medispan-support@wolterskluwer.com.
RxNorm Data Changes
Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY) Added
The Pfizer-BioNTech COVID-19 vaccine received U.S. Food and Drug Administration (FDA) approval on August 23, 2021, for individuals ages 16 years and older. Once vaccines are approved by the FDA, companies can market the vaccines under brand names. COMIRNATY is the brand name for the Pfizer-BioNTech COVID-19 vaccine.
The FDA-authorized Pfizer-BioNTech COVID-19 vaccine for individuals ages 16 years and older will be marketed as COMIRNATY towards the end of March 2022. No change was made to the vaccine’s formula with the name change. Pfizer-BioNTech COVID-19 vaccine (also known as COMIRNATY) overview and safety information is available from the U.S. Centers for Disease Control and Prevention.
Here is the new COMIRNATY product concept in RxNorm:
| RXCUI | TTY | STRING |
|---|---|---|
| 2593847 | SBD | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension [Comirnaty] |
Data Counts
| Term Type or Attribute | Number |
|---|---|
| Active GPCKs | 452 |
| Active BPCKs | 527 |
| Active SCDs | 17121 |
| Active SBDs | 9444 |
| Active RXNORM MINs | 3769 |
| Active RXNORM INs | 13739 |
| Active RXNORM PINs | 3253 |
| Active RXNORM BNs | 5106 |
| Active RXNORM DFs | 121 |
| Obsolete GPCKs | 248 |
| Obsolete BPCKs | 215 |
| Obsolete SCDs | 18643 |
| Obsolete SBDs | 11101 |
| Obsolete RXNORM MINs | 0 |
| Obsolete RXNORM INs | 0 |
| Obsolete RXNORM PINs | 0 |
| Obsolete RXNORM BNs | 6260 |
| Obsolete RXNORM DFs | 63 |
| Editor-suppressed SCDs | 1874 |
| Editor-suppressed SBDs | 1542 |
| SAB=RXNORM NDCs | 239180 |
| Distinct SAB=RXNORM NDCs | 239180 |
Last Reviewed: March 7, 2022